Abraham Stijn Meijnikman
Amsterdam Neuroscience1 paperORCID 0000-0002-6015-4656OpenAlex
Papers
Nature MetabolismHuman trial
Dasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial
The senolytic combination improved liver fibrosis without disease worsening in nearly half of treated participants while lowering cellular senescence…The senolytic combination improved liver fibrosis without disease worsening in nearly half of treated participants while lowering cellular senescence markers.